All Type of News
Korea to cover cost-effective medicines
The government plans to permit the national health insurance to cover only cost-effective drugs to reduce snowballing medication costs as an increasing number of patients are taking more expensive and diverse dr...
Novartis Korea, KFDA mulls voluntary withdrawal of Zelmac
Novartis Korea said on April 2 it discussed with the Korea Food and Drug Administration on the possibility of Zelmac (tegaserod) withdrawal from the market.
The U.S. Food and Drug Administration said on March 30 th...
Choongwae under stock holding company system.
Choongwae announced on April 2 that the company will separate the management with Choongwae Holdings (temporary) for the investment and Choongwae Pharmaceuticals for the business effective from July 1 this year. The e...
KFDA to approve an oral quit-smoking remedy, Champix.
The KFDA announced an approval of Champix (varenicline tartrate), an oral quit-smoking remedy as of March 30 filed by Pfizer Korea based on the clinical study evidences of showing 60% success in quitting smoking. Now,...
KFDA announces safety information of pergolide products
The Korea Food and Drug Administration issued a warning letter of the prescribing information for pergolide mesylate (Permax) to inform healthcare professionals of reports of cardiac valvulopathy involving one or more...
Notice to our readers
Thursday, April 5, 2007 is the anniversary of the founding of Yakup Shinmoon.
English Yakup Daily will not publish April 6(Friday).
- management-
Prescription by generic name will emerge as campaign issue
Prescription by generic name and will become a hot issue for presidential contenders and their parties ahead of the crucial election in December, according to the Korea Pharmaceutical Association.
The KPA said poli...
Director Kang Moon-seok of Dong-A named new vice presidentDirector Kang Moon-seok of Dong-A was appointed to the new vice president as a registered representing director of the company in the 23rd general shareholder's meeting on March...
|
.jpg)
Pfizer Korea to lead local educations for clinical R&D.
Pfizer Korea announced on March 29 that the company would launch diverse education programs of the R&D of clinical studies even for the college students starting from Ewha Univ. on March 31 to other 6 universities and...
Labeling changes for 39 drugs
The Korea Food and Drug Administration said it has approved labeling changes for 39 items from 26 pharmaceutical firms based on the evaluation of its safety information.
An observation reported in the labeling is t...
